|
|
 |
 |
| Proteins Congress 2010 is administered by Osney Media. |
|
|
|
|
 |
 |
| Next Event |
|
|
The Proteins Congress 2010
Thursday 28th October 2010 to Friday 29th October 2010 Kempinski Bristol Berlin Hotel, Berlin, Germany
|
|
More
|
|
|
|
 |
|
| Oxford Global conferences’ strict delegate screening criteria and one to one meeting selection facility allow you to reach a large number of pre-qualified decision makers and make the most of your time at the event. |
|
Read More
|
|
|
| Speakers |
 |
|
| The Proteins Congress 2010 consists of a unique blend of presentations, panel discussions and one to one business meetings. If you have a cutting edge case study or a thought provoking presentation join us at the event. |
|
Read More
|
|
|
|
|
|
|
|
| Featured Speakers |
|
|
|
Alexandra Alderton,
Primary Pharmacology Group, Pfizer
|
 |
|
|
Simon Brack,
Head of Lead Discovery, Covagen AG
|
|
|
|
Rolf Brekken,
Assistant Professor of Surgery and Pharmacology, UT Southwestern Medical Center, Dallas
|
|
|
|
Nicola Burgess Brown,
Head of Biotechnology, Oxford, The Structural Genomics Consortium
|
|
|
|
Paul Carter,
Investigator, GSK
|
|
|
|
Naomi Chayen,
President of the International Organisation for Biological Crystallization, Department of BioMolecular Medicine, SORA Division, Faculty of Medicine, Imperial College London
|
|
|
|
Giuseppe Ciaramella,
Executive Director Head of Biotherapeutics, Sandwich, Pfizer
|
|
|
|
Jeff Culp,
Associate Research Fellow, Primary Pharmacology Group, Pfizer Global Research & Development
|
|
|
|
Michael Dyson,
Senior Research Associate, Department of Biochemistry, University of Cambridge
|
|
|
|
Michael Feldhaus,
Senior Director of Antibody Engineering, Adimab
|
|
|
|
Joachim Feldwisch,
Project Manager, Affibody AB
|
|
|
|
Gianpaolo Fogliatto,
Senior Scientist, Project Leader, Nerviano Medical Sciences
|
|
|
|
Robert Hayes,
Venture Leader, Centyrex, Johnson & Johnson Ventures
|
|
|
|
Christian Heinis,
Group Head, Laboratory of Therapeutic Peptides and Proteins, Ecole Polytechnique Federal de Lausanne (EPFL)
|
|
|
|
Syd Johnson,
VP, Antibody Engineering, Macrogenics
|
|
|
|
John Liddell,
Head of Process Science, Avecia Biologics
|
|
|
|
Tomas Lundqvist,
Director Cell Protein and Structural Sciences (CPSS) DECS, AstraZeneca
|
|
|
|
Felix Oehme,
Biotech Development, Bayer Schering Pharma AG
|
|
|
|
Sigurd Okkels,
Vice President, Biologics Department, Discovery and Proof of Concept Development, Nycomed GmbH
|
|
|
|
Matthias Peipp,
Section of Stem Cell Transplantation and Immunotherapy, Christian Albrechts University
|
|
|
|
Søren K. Rasmussen,
Senior Scientist, Antibody Expression, Symphogen A/S
|
|
|
|
Pier Giorgio Righetti,
Professor, Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano
|
|
|
|
Diego Rodirguez Cabaleiro,
Biopharmaceutical Business Development Manager, Chemistry Operations, Waters European Headquarters, Guyancourt, France
|
|
|
|
Aaron Sato,
Senior Director of Antibody Engineering, OncoMed Pharmaceuticals
|
|
|
|
Arne Skerra,
Professor of Biological Chemistry, Technische Universitaet Muenchen, Freising-Weihenstephan, Germany
|
|
|
|
Peter Sondermann,
CSO, SuppreMol GmbH
|
|
|
|
Klaus Strein,
Head Pharmaceutical Research, Penzberg (Germany), F. Hoffmann-La Roche
|
|
|
|
Dominic Tisi,
Senior Scientist, Astex Therapeutics
|
|
|
|
David Urech,
Head of R&D, ESBA Tech
|
|
|
|
Barbara Valsasina,
Senior Scientist, Biology Dpt, Nerviano Medical Sciences
|
|
|
|
Paul Watt,
Vice President Drug Discovery, Phylogica
|
|
|
|
Ulrich Wendt,
Director of Structural Biology, Sanofi Aventis
|
|
|
|
Trevor Wilkinson,
Head of Protein Sciences, MedImmune
|
|
|
|
Yuan Xu,
Global Head/VP of Process Sciences, Production & Quality, Novartis Biologics
|
|
|
|
|
|
|
|
|
|
